WO1999005266A3 - Transfert de noyau entre des especes differentes - Google Patents

Transfert de noyau entre des especes differentes Download PDF

Info

Publication number
WO1999005266A3
WO1999005266A3 PCT/US1998/015387 US9815387W WO9905266A3 WO 1999005266 A3 WO1999005266 A3 WO 1999005266A3 US 9815387 W US9815387 W US 9815387W WO 9905266 A3 WO9905266 A3 WO 9905266A3
Authority
WO
WIPO (PCT)
Prior art keywords
nuclear transfer
trans
donor cells
species nuclear
oocytes
Prior art date
Application number
PCT/US1998/015387
Other languages
English (en)
Other versions
WO1999005266A2 (fr
WO1999005266B1 (fr
Inventor
Neal L First
Tanja Dominko
Maissam Mitalipoua
Original Assignee
Wisconsin Alumni Res Found
Neal L First
Tanja Dominko
Maissam Mitalipoua
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found, Neal L First, Tanja Dominko, Maissam Mitalipoua filed Critical Wisconsin Alumni Res Found
Priority to AU85875/98A priority Critical patent/AU8587598A/en
Publication of WO1999005266A2 publication Critical patent/WO1999005266A2/fr
Publication of WO1999005266A3 publication Critical patent/WO1999005266A3/fr
Publication of WO1999005266B1 publication Critical patent/WO1999005266B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8771—Bovine embryos

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

On décrit un procédé permettant de produire des embryons clonés par transfert nucléaire à partir de cellules donneuses différenciées. Le procédé consiste à cultiver des cellules donneuses différenciées dans un milieu pauvre en sérum et à utiliser en tant qu'ovocyte récepteur des ovocytes de bovins pour des cellules donneuses provenant d'espèces différentes. On peut utiliser ce procédé pour produire des animaux génétiquement identiques et des animaux transgéniques.
PCT/US1998/015387 1997-07-26 1998-07-24 Transfert de noyau entre des especes differentes WO1999005266A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU85875/98A AU8587598A (en) 1997-07-26 1998-07-24 Trans-species nuclear transfer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5310397P 1997-07-26 1997-07-26
US60/053,103 1997-07-26

Publications (3)

Publication Number Publication Date
WO1999005266A2 WO1999005266A2 (fr) 1999-02-04
WO1999005266A3 true WO1999005266A3 (fr) 1999-04-15
WO1999005266B1 WO1999005266B1 (fr) 1999-09-23

Family

ID=21981947

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/015387 WO1999005266A2 (fr) 1997-07-26 1998-07-24 Transfert de noyau entre des especes differentes

Country Status (2)

Country Link
AU (1) AU8587598A (fr)
WO (1) WO1999005266A2 (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517780D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US7696404B2 (en) 1996-08-19 2010-04-13 Advanced Cell Technology, Inc. Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
NZ334016A (en) * 1996-08-19 2000-08-25 Univ Massachusetts Embryonic stem cell lines produced by cross species nuclear transplantation
EP1060243A4 (fr) * 1998-03-02 2005-03-09 Univ Massachusetts Lignees cellulaires embryonnaires ou de type souche produites par transplantation nucleaire d'especes croisees
EP1067834A4 (fr) * 1998-03-16 2002-01-23 Garelag Pty Ltd Transfert de noyau de cellules porcines
AU782286B2 (en) 1999-06-30 2005-07-14 Advanced Cell Technology, Inc. Cytoplasmic transfer to de-differentiate recipient cells
JP2003503045A (ja) * 1999-06-30 2003-01-28 ワン，ウー−サク 異種間核移植技術を用いたクローントラの生産方法
RU2216591C2 (ru) * 1999-06-30 2003-11-20 Воо-Сук ХВАНГ Способ получения клонированных эмбрионов человека путем применения способа межвидовой трансплантации ядер
CA2334382A1 (fr) * 1999-06-30 2001-01-04 Woo-Suk Hwang Procede de production de vaches clonees
BR0013999A (pt) * 1999-09-14 2002-05-21 Univ Massachusetts Public Inst Linhagens de célula embriÈnicas ou semelhantes a células tronco produzidas por transplante nuclear de espécies cruzadas e métodos para melhorar o desenvolvimento embriÈnico por alteração genética de células doadoras ou por condições de cultura de tecido
MXPA02006093A (es) * 1999-12-20 2004-08-23 Univ Massachusetts Celulas tipo madre o embrionicas producidas por transplante nuclear de especies de cruza.
WO2003018767A2 (fr) 2001-08-27 2003-03-06 Advanced Cell Technology, Inc. Transdifferenciation et redifferenciation de cellules somatiques et production de cellules pour therapies cellulaires
ES2933478T3 (es) 2005-08-03 2023-02-09 Astellas Inst For Regenerative Medicine Métodos mejorados de reprogramación de células somáticas animales
WO2013010045A1 (fr) 2011-07-12 2013-01-17 Biotime Inc. Nouveaux procédés et formulations pour thérapie cellulaire orthopédique
SG11201508028QA (en) 2013-04-16 2015-10-29 Regeneron Pharma Targeted modification of rat genome
CN105980568B (zh) 2013-12-11 2019-12-03 瑞泽恩制药公司 用于靶向修饰基因组的方法和组合物
DK3080279T3 (en) 2013-12-11 2018-11-05 Regeneron Pharma METHODS AND COMPOSITIONS FOR TARGETED MODIFICATION OF A GENOM
CA2950173C (fr) 2014-06-06 2023-10-10 Regeneron Pharmaceuticals, Inc. Procedes et compositions pour la modification d'un locus cible
RU2771532C2 (ru) 2014-06-26 2022-05-05 Регенерон Фармасьютикалз, Инк. Способы и композиции для нацеленных генетических модификаций и способы их применения
CN113444747A (zh) 2014-11-21 2021-09-28 瑞泽恩制药公司 使用成对向导rna进行靶向遗传修饰的方法和组合物
CN107208113A (zh) 2014-12-19 2017-09-26 瑞泽恩制药公司 用于通过单步多重靶向进行靶向遗传修饰的方法和组合物
SG11201706809WA (en) 2015-03-16 2017-09-28 Regeneron Pharma Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
ES2784360T3 (es) 2015-05-29 2020-09-24 Regeneron Pharma Animales no humanos que tienen una interrupción en un locus C9ORF72
CN109195443A (zh) 2016-02-16 2019-01-11 雷杰纳荣制药公司 具有突变型犬尿氨酸酶基因的非人动物
EP3457840B1 (fr) 2016-05-20 2024-04-10 Regeneron Pharmaceuticals, Inc. Procédés pour briser la tolérance immunologique à l'aide de multiples arn de guidage
JP2019523009A (ja) 2016-07-29 2019-08-22 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｃ末端切断型フィブリリン−１の発現をもたらす変異を有するマウス
MX2019003745A (es) 2016-09-30 2019-12-11 Regeneron Pharma Animales no humanos que tienen una expansion de repeticiones de hexanucleotidos en un locus c9orf72.
ES2953875T3 (es) 2017-02-27 2023-11-16 Regeneron Pharma Modelos de retinosquisis en roedor
EP3644722A1 (fr) 2017-06-27 2020-05-06 Regeneron Pharmaceuticals, Inc. Animaux non humains comprenant un locus asgr1
EP3585159A1 (fr) 2017-07-31 2020-01-01 Regeneron Pharmaceuticals, Inc. Cellules souches embryonnaires de souris transgéniques cas et souris et leurs utilisations
AU2018309714A1 (en) 2017-07-31 2020-01-30 Regeneron Pharmaceuticals, Inc. Assessment of CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo
BR112020001996A2 (pt) 2017-07-31 2020-08-18 Regeneron Pharmaceuticals, Inc. animal não humano, e, métodos para testar e para otimizar a capacidade de uma crispr/cas nuclease de excisar um ácido nucleico genômico in vivo, para testar a recombinação induzida por crispr/cas de um ácido nucleico genômico com um ácido nucleico de doador exógeno in vivo e para otimizar a capacidade de crispr/cas de induzir a recombinação de um ácido nucleico genômico com um ácido nucleico de doador exógeno in vivo.
JP7139419B2 (ja) 2017-09-29 2022-09-20 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化ｔｔｒ遺伝子座を含む非ヒト動物および使用方法
CN111565566B (zh) 2017-11-10 2022-10-21 瑞泽恩制药公司 包含slc30a8突变的非人动物及使用方法
US11419318B2 (en) 2017-11-30 2022-08-23 Regeneran Pharmaceuticals, Inc. Genetically modified rat comprising a humanized TRKB locus
CN111885915B (zh) 2018-03-19 2023-04-28 瑞泽恩制药公司 使用crispr/cas系统对动物进行转录调制
CA3112612C (fr) 2018-09-13 2024-02-27 Regeneron Pharmaceuticals, Inc. Rat a invalidation genique de facteur h de complement en tant que modele de glomerulopathie c3
MX2021007400A (es) 2018-12-20 2021-07-15 Regeneron Pharma Expansion de repeticiones mediada por nucleasas.
ES2966625T3 (es) 2019-04-04 2024-04-23 Regeneron Pharma Roedores que comprenden un locus del factor de coagulación 12 humanizado
CA3137761A1 (fr) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Animaux non humains comprenant un locus ttr humanise ayant une mutation beta-slip et procedes d'utilisation
EP3796776A1 (fr) 2019-06-07 2021-03-31 Regeneron Pharmaceuticals, Inc. Animaux non humains comprenant un locus d'albumine humanisé
CN114008193A (zh) 2019-06-27 2022-02-01 瑞泽恩制药公司 Tdp-43蛋白病的建模
WO2021108363A1 (fr) 2019-11-25 2021-06-03 Regeneron Pharmaceuticals, Inc. Régulation à la hausse médiée par crispr/cas d'un allèle ttr humanisé
US20210227812A1 (en) 2020-01-28 2021-07-29 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
WO2021158883A1 (fr) 2020-02-07 2021-08-12 Regeneron Pharmaceuticals, Inc. Animaux non humains comprenant un locus klkb1 humanisé et procédés d'utilisation
US20230102342A1 (en) 2020-03-23 2023-03-30 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
WO2021263146A2 (fr) 2020-06-26 2021-12-30 Regeneron Pharmaceuticals, Inc. Animaux non humains comprenant un locus d'ace2 humanisé
AU2022381205A1 (en) 2021-11-04 2024-03-28 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a modified cacng1 locus
AU2022408167A1 (en) 2021-12-08 2024-06-06 Regeneron Pharmaceuticals, Inc. Mutant myocilin disease model and uses thereof
CN113943712B (zh) * 2021-12-20 2022-03-22 南京岚轩生物科技有限公司 一种电融合缓冲液、其制备方法及电融合方法
WO2023122506A1 (fr) 2021-12-20 2023-06-29 Regeneron Pharmaceuticals, Inc. Animaux non humains comprenant des loci ace2 et tmprss humanisés
WO2023150798A1 (fr) 2022-02-07 2023-08-10 Regeneron Pharmaceuticals, Inc. Compositions et procédés permettant de définir des délais de traitement optimaux dans le cadre d'une maladie lysosomale
US20230257432A1 (en) 2022-02-11 2023-08-17 Regeneron Pharmaceuticals, Inc. Compositions and methods for screening 4r tau targeting agents
WO2023235677A1 (fr) 2022-05-31 2023-12-07 Regeneron Pharmaceuticals, Inc. Modèle animal de protéinopathie tdp-43
WO2024026488A2 (fr) 2022-07-29 2024-02-01 Regeneron Pharmaceuticals, Inc. Animaux non humains comprenant un locus de récepteur de transférrine modifié
WO2024031053A1 (fr) 2022-08-05 2024-02-08 Regeneron Pharmaceuticals, Inc. Variants de tdp-43 résistants à l'agrégation
US20240130341A1 (en) 2022-09-29 2024-04-25 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496720A (en) * 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
WO1997007669A1 (fr) * 1995-08-31 1997-03-06 Roslin Institute (Edinburgh) Populations de cellules quiescentes pour transfert de noyau
WO1998007841A1 (fr) * 1996-08-19 1998-02-26 University Of Massachusetts Lignees de cellules embryonnaires ou de type souche produites par transplantation nucleaire croisee d'especes
WO1998030683A2 (fr) * 1997-01-10 1998-07-16 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts Transfert nucleaire au moyen de cellules donneuses foetales et adultes differentiees

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496720A (en) * 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
WO1997007669A1 (fr) * 1995-08-31 1997-03-06 Roslin Institute (Edinburgh) Populations de cellules quiescentes pour transfert de noyau
WO1998007841A1 (fr) * 1996-08-19 1998-02-26 University Of Massachusetts Lignees de cellules embryonnaires ou de type souche produites par transplantation nucleaire croisee d'especes
WO1998030683A2 (fr) * 1997-01-10 1998-07-16 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts Transfert nucleaire au moyen de cellules donneuses foetales et adultes differentiees

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHESNE P ET AL: "NUCLEAR TRANSFER IN CATTLE: BIRTH OF CLONED CALVES AND ESTIMATION OF BLASTOMERE TOTIPOTENCY IN MORULAE USED AS A SOURCE OF NUCLEI", LIFE SCIENCES, vol. 316, 1993, pages 487 - 491, XP000197855 *
HEYMAN Y ET AL: "CLONING OF DOMESTIC SPECIES", ANIMAL REPRODUCTION SCIENCE, vol. 42, no. 1/04, 1996, pages 427 - 436, XP000671884 *
SIMS M ET FIRST: "PRODUCTION OF CALVES BY TRANSFER OF NUCLEI FROM CULTURED INNER CELL MASS CELLS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 90, no. 13, June 1993 (1993-06-01), pages 6143 - 6147, XP000604993 *
STICE S L ET AL: "PLURIPOTENT BOVINE EMBRYONIC CELL LINES DIRECT EMBRYONIC DEVELOPMENT FOLLOWING NUCLEAR TRANSFER", BIOLOGY OF REPRODUCTION, vol. 54, no. 1, January 1996 (1996-01-01), pages 100 - 110, XP000671718 *
WOLFE, B.A. ET AL.: "Embryos produced by the transfer of caprine nuclei to enucleated bovine oocytes are capable of cleavage but not to develop to blastocysts", BIOLOGY OF REPRODUCTION, vol. 50, no. suppl. 1, 1994 - 1972, pages 72, XP002092259 *
ZAWADA, W.M. ET AL.: "Somatic cell cloned transgenic bovine neurons for transplantation in Parkinsonian rats", NATURE MEDICINE, vol. 4, no. 5, May 1998 (1998-05-01), pages 569 - 574, XP002092260 *

Also Published As

Publication number Publication date
WO1999005266A2 (fr) 1999-02-04
WO1999005266B1 (fr) 1999-09-23
AU8587598A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
WO1999005266A3 (fr) Transfert de noyau entre des especes differentes
WO1998030683A3 (fr) Transfert nucleaire au moyen de cellules donneuses foetales et adultes differentiees
EP1017423A4 (fr) Clonage de porcs a l'aide de noyaux donneurs a partir de cellules differenciees
AU1595195A (en) Embryonic stem cells as nuclear donors and nuclear transfer techniques to produce chimeric and transgenic animals
ATE318307T1 (de) Kultur einer zelllinieaus der inneren zellmasse von huftierembryonen.
WO2000031237A3 (fr) Procede de clonage de porcins
EP1780263A3 (fr) Procédé de production de culture de céllules aviaires indifférenciées, au moyen de céllules gérminales primordiales
WO2002072762A3 (fr) Utilisation d'interference de l'arn pour produire des cellules souches de lignee specifique et d'autres cellules non differenciees, et production de cellules differenciees in vitro par coculture
GB2350619B (en) Sex-specific insemination of mammals with low number of sperm cells
BR9506652A (pt) Materiais e métodos para gerenciamento de rejeição hiperaguda em xenotransplante em ser humano
EP1045635A4 (fr) Clonage faisant appel a des noyaux donnes de cellules foetales et adultes differenciees
NZ502712A (en) Medium and method for long term culturing of avian primordial germ cells (PGC) in a tissue culture comprising growth factors
EP1088057A4 (fr) Procede et milieu pour la culture in vitro d'embryons humains
WO2001042421A3 (fr) Compositions pour culture cellulaire a long terme et animaux genetiquement modifies derives de ces compositions
MXPA02006094A (es) Metodos para producir embriones clonadod y adultos a partir de celulas cultivadas.
AU695398B2 (en) Method of production of transgenic plants wholly transformed into To generation, from meristems
NO912621L (no) Fremgangsmaate for innfoering av dna i animalske celler.
WO2001049106A3 (fr) Procede de clonage d'animaux avec modifications genetiques ciblees, par transfert de noyaux cellulaires somatiques males ou femelles a culture a long terme, comprenant des modifications genetiques provoquees artificiellement, dans des cellules receveuses enuclees
WO2001068831A3 (fr) Reprogrammation effective de materiel nucleaire chez des mammiferes
NO20006545L (no) Fremgangsmåte for in vitro modning av humane kjönnsceller
AU570954B2 (en) Propagation of proliferating cell aggregates
IE881133L (en) In-vitro culture of bovine embryos
IE890289L (en) Bovine embryo in vitro culture
AU3927599A (en) Source of nuclei for nuclear transfer
AU6292898A (en) Efficient nuclear transfer using primordial germ cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: B1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 09463276

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA